Form 4: CareDx Director Riggsbee Receives RSU Grant
Statement of Changes in Beneficial Ownership
Director Richard Bryan Riggsbee was granted 9,795 restricted stock units in CareDx, Inc. as part of standard equity compensation.
Summary
- Director Richard Bryan Riggsbee acquired 9,795 restricted stock units (RSUs) of CareDx, Inc. common stock.
- The transaction occurred on June 12, 2026.
- The RSUs were granted at a price of $0 per share.
- Following this transaction, the director's total beneficial ownership increased to 39,312 shares.
- The RSUs vest on the earlier of the one-year anniversary of the grant or the day before the first Annual Meeting following the grant date.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral, routine administrative filing regarding director compensation.
Positives
- Alignment of director interests with shareholders through equity-based compensation.
- Standardized vesting schedule ensures long-term commitment to the company.
Negatives
- None identified; this is a routine equity grant for a board member.
Risks
- Vesting is subject to the director's continuous service to the company.
Future Outlook
The RSUs are expected to vest within one year, subject to continued service.
Industry Context
StockSavvy.ai notes that equity grants to non-employee directors are standard corporate governance practices in the biotechnology sector to ensure board alignment with long-term shareholder value.
Comparison to Industry Standards
- The grant of RSUs to directors is consistent with standard compensation practices for mid-cap biotechnology companies.
- The vesting period of one year or the next annual meeting is a common industry benchmark for director equity awards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Authorization of Jeffrey Adam Novack and Colleen Martin-Garcia to file Section 16 reports on behalf of the director. | 07/18/2025 | Standard administrative procedure to ensure timely regulatory compliance. |
Stakeholder Impact
- Shareholders: Minimal impact; reflects standard director compensation structure.
Next Steps
- Vesting of the 9,795 RSUs on the earlier of the one-year anniversary or the next Annual Meeting.
Key Dates
| Date | Description |
|---|---|
| 07/18/2025 | Date of Power of Attorney execution. |
| 06/12/2026 | Date of RSU grant transaction. |
| 06/16/2026 | Date of filing. |
Keywords
CareDx, CDNA, Form 4, Director Compensation, Restricted Stock Units, Insider Transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.